Spots Global Cancer Trial Database for A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System
Official Title: A Prospective, Block Stratified Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System
Study ID: NCT03300206
Conditions
Interventions
Study Description
Brief Summary: The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System as compared to the current standard-of-care breast biopsy procedures
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
HonorHealth, Phoenix, Arizona, United States
Kensington Medical Center - Kaiser Permanente, Kensington, Maryland, United States
Washington University, Saint Louis, Missouri, United States
Elizabeth Wende Breast Center, Rochester, New York, United States
Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
MD Anderson Cancer Center, Houston, Texas, United States
University of Utah - Huntsman Cancer Hospital, Salt Lake City, Utah, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
